Literature DB >> 11753641

p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.

M Bakhanashvili1.   

Abstract

The tumor suppressor protein p53 plays a critical role in the maintenance of genetic integrity. p53 possesses 3'-->5' exonuclease activity, however, the significance of this function in DNA replication process remains elusive. It was suggested that 3'-->5' exonuclease activity of p53 may provide a proofreading function for DNA polymerases. In order to better understand the significance of this activity, the purified wild-type recombinant p53 was further evaluated for substrate specificity and for contribution to the accuracy of DNA synthesis. p53-associated 3'-->5' exonuclease displays 3' terminal nucleotide excision from RNA/DNA template-primer using ribosomal RNA as a template. The data demonstrate that p53 is highly efficient in removing a terminal mispair. Analysis of mispair excision opposite the template adenine residue shows that p53 catalyzes 3' terminal mismatch excision with a specificity of A : G>A : A>A : C. Hence, the observed specificity of mismatch excision indicates that p53 exonucleolytic proofreading preferentially repairs transversion mutations. The influence of the p53 on the accuracy of DNA synthesis was determined with exonuclease-deficient human immunodeficiency virus-1 (HIV-1) reverse transcriptase (RT), a key enzyme in the life cycle of the virus, that contributes significantly to the low accuracy of proviral DNA synthesis. Using an in vitro biochemical assay with recombinant purified HIV-1 RT, p53 and defined RNA/DNA or DNA/DNA template-primers, two basic features related to fidelity of DNA synthesis were studied: the misinsertion and mispair extension. The misincorporation of non-complementary deoxynucleotides into nascent DNA and subsequent mispair extension by HIV-1 RT were substantially decreased in the presence of p53 with both RNA/DNA and DNA/DNA template-primers. In addition, the productive interaction between polymerization (by HIV-1 RT) and exonuclease (by p53) activities was observed; p53 preferentially hydrolyzes mispaired 3'-termini, permitting subsequent extension of the correctly paired 3'-terminus by HIV-1 RT. Taken together the data demonstrate that preferential excision of mismatched nucleotides by 3'-->5' exonuclease activity of wild-type p53 enhances the fidelity of DNA synthesis by HIV-1 RT in vitro, thus providing a biochemical mechanism to reduce mutations caused by incorporation of mismatched nucleotides. The fact that p53 is reactive with both RNA/DNA and DNA/DNA template-primers raises an interesting possibility of the existence of functional cooperation between p53 and HIV-1 RT in cytoplasm during the reverse transcription process, which may be important for maintaining HIV genomic integrity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11753641     DOI: 10.1038/sj.onc.1204956

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

2.  Exonucleolytic degradation of RNA by p53 protein in cytoplasm.

Authors:  Mary Bakhanashvili; Rachel Gedelovich; Shai Grinberg; Galia Rahav
Journal:  J Mol Med (Berl)       Date:  2007-08-15       Impact factor: 4.599

3.  Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Mary Bakhanashvili; Elena Novitsky; Ethan Rubinstein; Itzchak Levy; Galia Rahav
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 4.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

5.  Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74V.

Authors:  Prem L Sharma; James H Nettles; Anya Feldman; Kimberly Rapp; Raymond F Schinazi
Journal:  Antiviral Res       Date:  2009-06-23       Impact factor: 5.970

6.  A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.

Authors:  Himabindu Chunduri; David Rimland; Viktoria Nurpeisov; Clyde S Crumpacker; Prem L Sharma
Journal:  Virol J       Date:  2011-01-21       Impact factor: 4.099

7.  Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.

Authors:  Luis Menéndez-Arias
Journal:  Viruses       Date:  2009-12-04       Impact factor: 5.048

8.  Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.

Authors:  Matthias Paar; Dieter Klein; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  BMC Mol Biol       Date:  2009-02-09       Impact factor: 2.946

9.  Early and transient reverse transcription during primary deltaretroviral infection of sheep.

Authors:  Carole Pomier; Maria T Sanchez Alcaraz; Christophe Debacq; Agnes Lançon; Pierre Kerkhofs; Lucas Willems; Eric Wattel; Franck Mortreux
Journal:  Retrovirology       Date:  2008-02-01       Impact factor: 4.602

10.  Inhibition of HIV early replication by the p53 and its downstream gene p21.

Authors:  Binshan Shi; Hamayun J Sharifi; Sara DiGrigoli; Michaela Kinnetz; Katie Mellon; Wenwei Hu; Carlos M C de Noronha
Journal:  Virol J       Date:  2018-03-27       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.